Access cutting-edge pulmonary arterial hypertension treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access pulmonary arterial hypertension specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary arterial hypertension treatment provided free
The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World Health Organization (WHO) Group 1 on standard of care (SoC). There is no formal hypothesis.
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this pulmonary arterial hypertension clinical trial in Seattle, WA
If you're searching for pulmonary arterial hypertension treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary arterial hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.